Avalon GloboCare - ערך חשבונאי למניה ALBT

The optimization of drug and reagent distribution fueled the growth of Avalon GloboCare (ALBT), which triggered an uptrend on the chart. The BVPS metric reached a peak, after which the parameter stabilized at -1.82. The company is currently implementing green procurement and energy-efficient IT systems. Business stability is supported by its own network of laboratories and the development of cell-based therapies, which create significant barriers to entry for competitors.

Avalon GloboCare's possession of certified laboratories and research centers in the US forms the tangible foundation of the business value. This metric reflects the residual value of net assets allocated per share, allowing for an assessment of the balance sheet's intrinsic stability regardless of market volatility; therefore, a stable BVPS value confirms the preservation of the company's capital resources.